New Strategic Partnership: CNBE INRS and Wax-it Histology Services Inc.

New Strategic Partnership: CNBE INRS and Wax-it Histology Services Inc. VANCOUVER, BC AND LAVAL, QC. (April 11, 2018) — Wax-it Histology Services Inc. and CNBE (INRS) are pleased to announce a strategic partnership in the area of contractual research in laboratory animal experimentation and histology analysis services by joining their respective expertise. The new strike force […]

Read More

Why Should You Outsource Your Stability Testing?

Why Should You Outsource Your Stability Testing? Avomeen, LLC. Content Suggestions: Why Should You Outsource Your Stability Testing? Stability testing is an essential part of clinical trials, whether you plan to market your product in the U.S. or abroad. Unfortunately, because stability testing involves studying how a product changes over a long period, it’s inherently […]

Read More

BioBlocks’ CFL: Designed for Improved Lead Discovery

BioBlocks’ CFL: Designed for Improved Lead Discovery Screenable compounds in BioBlocks’ newly available Comprehensive Fragment Library (CFL) are selected for their improved chemical and pharmaceutical properties. Unlike traditional fragment screening sets of predominantly flat aromatic compounds, the typical CFL fragment features both aromatic and sp3 character in 15 atoms or less, with >95% containing handles […]

Read More

PATIENT RECRUITMENT: A PERSONALIZED APPROACH

PATIENT RECRUITMENT: A PERSONALIZED APPROACH April 05, 2018   I recently had the opportunity to visit with a few physicians in Central and Eastern Europe (CEE) and learn about their approach with clinical trials and patient recruitment. For our non-EU clients considering a clinical research in the EU, some differences in patient recruitment may be […]

Read More

Data exchange can be one of the biggest challenges impacting relationships between CROs and sponsors. How does your company overcome this issue and what standards of practice can be followed to mitigate issues? 

Data exchange can be one of the biggest challenges impacting relationships between CROs and sponsors. How does your company overcome this issue and what standards of practice can be followed to mitigate issues?  Data exchange is a part of the much broader issue of confidentiality when contracting R&D services.  In reality, regardless of the geographic […]

Read More

Australia Tax Incentives Spurring R&D

Australia tax incentives spurring R&D March 27, 2018 Australia is riding a wave of R&D, thanks to generous government tax incentives, as well as the quality of contract research and speed of performing clinical trials. The incentives provide businesses investing in eligible R&D, including clinical trials, with: A 43.5% refundable R&D tax offset for a […]

Read More

Improved Fragment Screening with BioBlocks’ CFL

Improved Fragment Screening with BioBlocks’ CFL BioBlocks’ Comprehensive Fragment Library (CFL) provides a powerful advantage for identifying high quality starting points for lead discovery and is now ready for drug discovery collaborations. As part of the Leap-to-Lead™ platform, the CFL was designed to meet strict property criteria, aided by our team’s deep expertise in medicinal […]

Read More